Bedel Financial Consulting, Inc. Moderna, Inc. Transaction History

Bedel Financial Consulting, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$109.18 - $185.98 $1,091 - $1,859	-10 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$65.74 - $169.86 $197 - $509	-3 Reduced 23.08%	10 $1,000
Q2 2020 Jul 14, 2020	BUY	$29.67 - $80.0 $89 - $240	3 Added 30.0%	13 $1,000
Q1 2020 May 06, 2020	BUY	$17.78 - $31.58 $177 - $315	10 New	10 $0

1,039

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.